Key Details
Price
$24.78Annual Revenue
$151.00 KAnnual ROE
-10.89%Beta
0.08Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
N/ARecent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
19 Nov '24 Wells Fargo
Overweight19 Nov '24 TD Cowen
Buy19 Nov '24 JP Morgan
Overweight19 Nov '24 Cantor Fitzgerald
OverweightScreeners with SEPN included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Septerna Common Stock doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering
SEPN
globenewswire.com30 October 2024
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery, today announced the closing of its upsized initial public offering (IPO) of 18,400,000 shares of its common stock at a public offering price of $18.00 per share, which includes an additional 2,400,000 shares issued upon the full exercise by the underwriters of their option to purchase additional shares. All of the shares were offered by Septerna.
FAQ
- What is the primary business of Septerna Common Stock?
- What is the ticker symbol for Septerna Common Stock?
- Does Septerna Common Stock pay dividends?
- What sector is Septerna Common Stock in?
- What industry is Septerna Common Stock in?
- What country is Septerna Common Stock based in?
- Is Septerna Common Stock in the S&P 500?
- Is Septerna Common Stock in the NASDAQ 100?
- Is Septerna Common Stock in the Dow Jones?
- When does Septerna Common Stock report earnings?
- Should I buy Septerna Common Stock stock now?
What is the primary business of Septerna Common Stock?
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. The company develops SEP-786, an oral small molecule PTH1R agonist for hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 NAM for chronic spontaneous urticaria and other mast cell diseases; TSHR Program, an oral small molecule TSHR NAM for Graves' disease and thyroid eye disease. It also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders including obesity and type 2 diabetes. Septerna, Inc. was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. The company was incorporated in 2019 and is headquartered in South San Francisco, California.
What is the ticker symbol for Septerna Common Stock?
The ticker symbol for Septerna Common Stock is NASDAQ:SEPN
Does Septerna Common Stock pay dividends?
No, Septerna Common Stock does not pay dividends
What sector is Septerna Common Stock in?
Septerna Common Stock is in the Healthcare sector
What industry is Septerna Common Stock in?
Septerna Common Stock is in the Biotechnology industry
What country is Septerna Common Stock based in?
Septerna Common Stock is headquartered in United States
Is Septerna Common Stock in the S&P 500?
No, Septerna Common Stock is not included in the S&P 500 index
Is Septerna Common Stock in the NASDAQ 100?
No, Septerna Common Stock is not included in the NASDAQ 100 index
Is Septerna Common Stock in the Dow Jones?
No, Septerna Common Stock is not included in the Dow Jones index
When does Septerna Common Stock report earnings?
The date for Septerna Common Stock's next earnings report has not been announced yet
Should I buy Septerna Common Stock stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions